Related Experiment Video
Updated: Nov 20, 2025

07:35
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
7.2K
Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers
Han-Mo Chiu1, Grace Hsiao-Hsuan Jen2, Ying-Wei Wang3
1Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Gut
|January 26, 2021
Summary
Faecal immunochemical test (FIT) screening significantly reduces advanced colorectal cancer (CRC) and CRC deaths by 34% and 40% respectively. This population-based screening shows greater long-term effectiveness in the distal colon compared to the proximal colon.
Area of Science:
- Gastroenterology
- Oncology
- Public Health
Background:
- Population-based screening programs are crucial for early detection of colorectal cancer (CRC).
- The faecal immunochemical test (FIT) is a widely adopted screening tool for CRC.
- Understanding the long-term effectiveness of FIT screening, particularly site-specific outcomes, is essential for optimizing public health strategies.
Purpose of the Study:
- To evaluate the long-term effectiveness of a nationwide, population-based faecal immunochemical test (FIT) screening program for colorectal cancer (CRC).
- To assess the impact of FIT screening on overall and site-specific incidence of advanced-stage CRC and CRC mortality.
- To provide evidence-based policy recommendations for sustainable CRC screening programs.
Main Methods:
- A prospective cohort study involving over 5.4 million Taiwanese individuals invited to biennial FIT screening from 2004-2009, with follow-up until 2014.
- Bayesian Poisson regression models were used to estimate adjusted relative rates (aRRs) for advanced-stage CRC and CRC death.
- Analyses accounted for self-selection factors, including screening and colonoscopy rates, and colonoscopy completeness, alongside demographic features.
Main Results:
- FIT screening significantly reduced the incidence of advanced-stage CRC by 34% (aRR=0.66) and CRC mortality by 40% (aRR=0.60).
- The effectiveness was more pronounced in reducing distal advanced-stage CRCs (aRR=0.61) and associated mortality (aRR=0.56) compared to proximal advanced CRCs (aRR=0.84) and their mortality (aRR=0.72).
- Incidence of advanced-stage CRC decreased from 75.7 to 48.4 per 100,000, and mortality from 41.3 to 20.3 per 100,000 in the screened group.
Conclusions:
- Large-scale, biennial FIT screening is effective in reducing advanced CRC incidence and mortality.
- The study highlights a significant disparity in long-term effectiveness, with greater benefits observed in the distal colon.
- Findings support the implementation of sustainable, population-based FIT screening programs globally and suggest a need to address lower effectiveness in proximal colon screening.

